首页 | 本学科首页   官方微博 | 高级检索  
检索        

替比夫定对慢性乙型肝炎患者T细胞亚群的影响
引用本文:邓良准,庄军.替比夫定对慢性乙型肝炎患者T细胞亚群的影响[J].广州医药,2010,41(5):23-24.
作者姓名:邓良准  庄军
作者单位:1. 中航工业3201医院感染科,陕西,汉中,723000
2. 解放军264医院,山西,太原,030001
摘    要:目的探讨替比夫定对慢性乙型肝炎(CHB)患者细胞免疫功能的影响。方法采用流式细胞术检测40例CHB患者在服用替比夫定前后外周血T细胞亚群,同时检测32例健康体检者外周血T细胞亚群作为对照组。结果 CHB组较健康对照组CD3 T细胞、CD4 T细胞百分比以及CD4/CD8明显降低(P〈0.05),CD8 T细胞百分比明显升高(P〈0.05)。CHB患者在使用替比夫定后,CD3 T细胞、CD4 T细胞百分比以及CD4/CD8有明显回升(P〈0.05),CD8 T细胞百分比则出现明显下降(P〈0.05)。结论替比夫定可改善CHB患者的细胞免疫功能。

关 键 词:替比夫定  T细胞亚群  慢性乙型肝炎

Effect of Telbivudine on T lymphocyte subsets in patients with chronic hepatitis B
Deng Liangzhun,Zhuang Jun.Effect of Telbivudine on T lymphocyte subsets in patients with chronic hepatitis B[J].Guangzhou Medical Journal,2010,41(5):23-24.
Authors:Deng Liangzhun  Zhuang Jun
Institution:1Department of Infections Disease,China Aviation Industry 3201 Hospital,Shanxi,Hanzhong 723000,China.2Department of Special Care,264 Hospital of PLA,Shanxi,Taiyuan 030001,China )
Abstract:Objective To investigate the effect of Telbivudine on cellular immune function of patients with chronic hepatitis B(CHB).Methods Flow cytometry was used to detect T lymphocyte subsets of 40 patients with CHB before and after Telbivudine therapy.In addition,32 healthy individuals were chosen as control group.Results The percentage of CD3 and CD4 T lymphocytes and the ratio of CD4/CD8 in patients with CHB are significantly reduced than those in healthy controls(P〈0.05).However,the percentage of CD8 T lymphocytes is significantly increased than that in healthy controls(P〈0.05).The percentage of CD3 and CD4 T lymphocytes and the ratio of CD4/CD8 are significantly higher than those before Telbivudine therapy(P〈0.05).The percentage of CD8 T lymphocytes is significantly lower than that before Telbivudine therapy(P〈0.05).Conclusion Telbivudine can improve the cellular immune function of patients with CHB.
Keywords:Telbivudine  T lymphocyte subsets  Chronic hepatitis B
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号